QILU PHARMACEUTICAL
Qilu Pharmaceutical is one of the leading pharmaceutical companies in China. Qilu focuses on the development, manufacturing and marketing of generic drugs and active pharmaceutical ingredients(APIs) in therapeutic areas including but not limited to Oncology, Cerebrovascular & Cardiovascular, Anti-infections, Psychological & Neurological Systems, Respiratory System, and Ophthalmological Diseases. Qilu has more than 15,000 employees, 70% of whom have a college degree or above. Qilu Pharmaceutical... consistently focuses on revolutionary development strategies guided by market demand and product innovation. Qilu has established extensive cooperation with domestic and international partners on multiple R&D projects. Devoted to the cultivation of talent, Qilu has invested in a highly qualified R&D team and efficient R&D capabilities. The 200+ new drug products successfully developed by Qilu constitutes as a large part of future production and sales for Qilu Pharmaceutical and partners. A number of technological achievements have garnered national and provincial scientific and technological progress awards for Qilu.
QILU PHARMACEUTICAL
Industry:
Pharmaceutical
Founded:
1958-01-01
Status:
Active
Contact:
+86-531-83127705
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Mobile Non Scaleable Content Amazon IPv6 Cloudflare Hosting Amazon Route 53
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-07-01 | Regor Therapeutics | Qilu Pharmaceutical investment in Series A - Regor Therapeutics | N/A |
More informations about "Qilu Pharmaceutical"
About us-Qilu pharmaceutical co.,ltd. | Caring through …
Established in 1958, Qilu Pharmaceutical is now one of the leading vertically integrated pharmaceutical companies in China that develops, manufactures and distributes both Finished Dosage Forms (FDFs) and Active Pharmaceutical …See details»
Qilu Pharmaceutical Co., Ltd. - Drug pipelines, Patents ... - Patsnap
Nov 1, 2024 Explore Qilu Pharmaceutical Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 434 clinical trials, 63 news, and 113 literature, Disease …See details»
Qilu Pharmaceutical - Crunchbase Investor Profile
Qilu Pharmaceutical is a large and comprehensive pharmaceutical company. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. ... 2,794 Number of Organizations • $476.2B …See details»
Qilu Pharma - Medtech Alert
Sep 26, 2022 Qilu Pharma is a leading vertically integrated pharmaceutical companies in China focused on discovering, developing, manufacturing and commercializing innovative medicines. With a diverse pipeline of noval …See details»
Qilu Pharmaceutical Co.Ltd
Qilu Pharmaceutical is one of the leading vertically integrated pharmaceutical companies in China, with a footprint in three segments: human medicines, veterinary medicines and crop …See details»
Qilu Pharmaceutical - Overview, News & Similar companies
Mar 4, 2024 Who is Qilu Pharmaceutical. Qilu Pharmaceutical is a leading vertically integrated pharmaceutical company focused on discovering, developing, manufacturing and …See details»
Qilu Pharmaceutical ranks No.3 in the list of "Top 100 Enterprises …
Jul 18, 2022 On September 7th, 2024, the list of "2023 Top 100 Enterprises in Chinese Pharmaceutical Industry" was released at the 41th Session of National Pharmaceutical …See details»
Qilu Pharmaceutical Co. Ltd. - BioCentury Company Profiles - BCIQ
Apr 21, 2023 Qilu Pharmaceutical Co. Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
Shanghai Qilu Pharmaceutical Research Center Co., Ltd.
Nov 1, 2024 Explore Shanghai Qilu Pharmaceutical Research Center Co., Ltd. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Neoplasms, Immune …See details»
Qilu Pharmaceutical Co., Ltd. DMF, CEP, Written ... - PharmaCompass
Qilu Pharmaceutical Co Ltd// Located in Jinan, Qilu Pharmaceutical is one of the leading pharmaceutical companies in China. It focuses on developing, manufacturing and marketing of …See details»
QILU PHARMA, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for QILU PHARMA, INC. of Malvern, PA. Get the latest business insights from Dun & Bradstreet.See details»
QLG1091 - Drug Targets, Indications, Patents - Synapse
Dec 9, 2024 QLG1091, Initially developed by Qilu Pharmaceutical Co., Ltd., Now, its global highest R&D status is IND Approval, Therapeutic Areas: Endocrinology and Metabolic ...See details»
Qilu Pharmaceutical Ranked No. 9 among Top 100 Chinese …
Aug 1, 2021 The list of the Top 100 Chinese Pharmaceutical Companies was released and Qilu pharmaceutical ranked No. 9. The company was also awarded as The Best R&D Pipeline …See details»
QLS31903 - Drug Targets, Indications, Patents - Synapse
Nov 21, 2024 QLS31903, Initially developed by Qilu Pharmaceutical Co., Ltd., Now, its global highest R&D status is Phase 1, Therapeutic Areas: Neoplasms, Active Indication ...See details»
Qilu Pharmaceutical DMF, CEP, Written Confirmations, FDF, Prices ...
Qilu Pharmaceutical// Located in Jinan, Qilu Pharmaceutical is one of the leading pharmaceutical companies in China. It focuses on developing, manufacturing and marketing of generic drugs …See details»
Preliminary Results of Qilu Pharmaceutical's Phase Ia Study on …
6 days ago Preliminary Results of Qilu Pharmaceutical's Phase Ia Study on GPRC5D/CD3-Targeting Bispecific Antibody QLS32015 Unveiled at 2024 ASH Annual Meeting PR Newswire …See details»
Pertuzumab biosimilar (Qilu Pharmaceutical) - Drug Targets
6 days ago Qilu Pharmaceutical's class 1 novel drug, QL1706, is a bifunctional antibody that simultaneously targets PD-1 and CTLA-4, producing synergistic anti-tumor effects. The phase …See details»
Ondansetron Hcl for Injection of Qilu was approved by USFDA
Nov 20, 2014 Recently, Ondansetron Hcl for Injection, manufactured by Qilu Pharmaceutical was approved by USFDA which means that it has been permitted to be sold in USA. As early …See details»
Qilu Pharmaceutical ranked 5th among China's top 100 list
Jul 18, 2022 Qilu Pharmaceutical Group ranked 5 th among China's top 100 pharmaceutical companies according to a list released by the 2022 China Medical and Health Industry …See details»
Qilu ranked top 10 of the Chinese Pharmaceutical Industry in 4 ...
Aug 4, 2018 The 35th National Pharmaceutical Industry Summit was held in Shanghai on Aug.4 th, 2018, and the top 100 list of the Chinese pharmaceutical companies was released at this …See details»